Show simple item record

dc.contributor.authorLin, S.
dc.contributor.authorSanchez-Bretaño, A.
dc.contributor.authorLeslie, J.S.
dc.contributor.authorWilliams, K.B.
dc.contributor.authorLee, H.
dc.contributor.authorThomas, N.S.
dc.contributor.authorCallaway, J.
dc.contributor.authorDeline, J.
dc.contributor.authorRatnayaka, J.A.
dc.contributor.authorBaralle, D.
dc.contributor.authorSchmitt, M.A.
dc.contributor.authorNorman, C.S.
dc.contributor.authorHammond, S.
dc.contributor.authorHarlalka, G.V.
dc.contributor.authorEnnis, S.
dc.contributor.authorCross, H.E.
dc.contributor.authorWenger, O.
dc.contributor.authorCrosby, A.H.
dc.contributor.authorBaple, E.L.
dc.contributor.authorSelf, J.E.
dc.date.accessioned2022-03-04T22:48:53Z
dc.date.available2022-03-04T22:48:53Z
dc.date.issued2022
dc.identifier.citationLin, S., Sanchez-Bretaño, A., Leslie, J. S., Williams, K. B., Lee, H., Thomas, N. S., Callaway, J., Deline, J., Ratnayaka, J. A., Baralle, D., Schmitt, M. A., Norman, C. S., Hammond, S., Harlalka, G. V., Ennis, S., Cross, H. E., Wenger, O., Crosby, A. H., Baple, E. L., & Self, J. E. (2022). Evidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B). Npj Genomic Medicine.
dc.identifier.issn2056-7944
dc.identifier.doi10.1038/s41525-021-00275-9
dc.identifier.urihttp://hdl.handle.net/10150/663479
dc.description.abstractOculocutaneous albinism type 1 (OCA1) is caused by pathogenic variants in the TYR (tyrosinase) gene which encodes the critical and rate-limiting enzyme in melanin synthesis. It is the most common OCA subtype found in Caucasians, accounting for ~50% of cases worldwide. The apparent ‘missing heritability’ in OCA is well described, with ~25–30% of clinically diagnosed individuals lacking two clearly pathogenic variants. Here we undertook empowered genetic studies in an extensive multigenerational Amish family, alongside a review of previously published literature, a retrospective analysis of in-house datasets, and tyrosinase activity studies. Together this provides irrefutable evidence of the pathogenicity of two common TYR variants, p.(Ser192Tyr) and p.(Arg402Gln) when inherited in cis alongside a pathogenic TYR variant in trans. We also show that homozygosity for the p.(Ser192Tyr)/p.(Arg402Gln) TYR haplotype results in a very mild, but fully penetrant, albinism phenotype. Together these data underscore the importance of including the TYR p.(Ser192Tyr)/p.(Arg402Gln) in cis haplotype as a pathogenic allele causative of OCA, which would likely increase molecular diagnoses in this missing heritability albinism cohort by 25–50%. © 2022, The Author(s).
dc.language.isoen
dc.publisherNature Research
dc.rightsCopyright © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleEvidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B)
dc.typeArticle
dc.typetext
dc.contributor.departmentDepartment of Ophthalmology, University of Arizona College of Medicine
dc.identifier.journalnpj Genomic Medicine
dc.description.noteOpen access journal
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal published version
dc.source.journaltitlenpj Genomic Medicine
refterms.dateFOA2022-03-04T22:48:53Z


Files in this item

Thumbnail
Name:
s41525-021-00275-9.pdf
Size:
1.306Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

Copyright © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License.
Except where otherwise noted, this item's license is described as Copyright © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License.